SIX-MONTH CONTRACEPTIVE EFFICACY TRIALS ARE ADEQUATE FOR BARRIER METHODS
This article was originally published in The Gray Sheet
Executive Summary
SIX-MONTH CONTRACEPTIVE EFFICACY TRIALS ARE ADEQUATE FOR BARRIER METHODS of preventing pregnancy, scientists participating in an April 6-8 FDA/National Institutes of Health/Centers for Disease Control and Prevention workshop on contraceptive efficacy and sexually transmitted disease prevention concluded. Speaking on the final day of the meeting, Jeffrey Spieler, of U.S.A.I.D., said "for all barrier methods, male and female barriers...the group agreed that six-month clinical trials [for prevention of pregnancy] would be sufficient" to gather the necessary safety and efficacy data to bring a product to market.
You may also be interested in...
Cosmetic And Personal Care Trademark Review: 16 April
Personal care and cosmetic product trademark filings compiled from the Official Gazette of the US Patent and Trademark Office, Class 3.
Health And Wellness Weekly Trademarks Review: 16 April
Trademarks are registered and published for opposition with the US Patent and Trademark Office and are published weekly in the agency's Official Gazette.
Beauty Packaging Producers: July Marks Registration Deadline With PRO In Three States
Companies considered producers of single-use packaging in Oregon, Colorado and California must register with Circular Action Alliance, the leading (and currently only) producer responsibility organization, by 1 July 2024 under new state recycling laws.